NSAIDs provide patients with quality of vision
October 15th 2006The use of nonsteroidal anti-inflammatory drugs (NSAIDs) before and after cataract surgery significantly lowers the incidence of cystoid macular edema (CME) and provides patients with better quality of vision. The results of three studies presented at the annual meeting of the American Society of Cataract and Refractive Surgery, San Francisco, bore out that finding.
Booster approach helps stabilize vision in AMD patients
October 15th 2006Winter Haven, FL-Combination therapy using bevacizumab (Avastin, Genentech) as a "booster shot" in conjunction with pegaptanib sodium (Macugen, OSI/Eyetech/Pfizer) to treat exudative age-related macular degeneration (AMD) appears to work very well in both the short term and the long term, according to Michael Tolentino, MD.
Central corneal thickness a marker of susceptibility?
October 15th 2006Results from a case study comparing inter-eye central corneal thickness (CCT) in patients with asymmetric glaucoma show a positive association between more advanced glaucomatous cupping and a thinner central cornea, according to Shawn J. Khan, MD, FRCSC.
Fluocinolone acetonide implant offers hope for patients with chronic macular edema
October 15th 2006Durham, NC-A fluocinolone acetonide sustained drug delivery system (Retisert, Bausch & Lomb) implanted in patients with chronic macular edema associated with retinal venous occlusive disease reduced the edema and improved visual acuity in a significant portion of the eyes of 19 patients enrolled in the first 12 months of a 3-year study.
Researchers consider meaningful endpoints in diabetic retinopathy clinical trials
October 15th 2006Madison, WI-The visual and morphology measurements used as endpoints in a clinical trial have both advantages and disadvantages that must be balanced by their value in achieving the goals of the study, according to Ronald Danis, MD.
Safety favorable with pediatric primary IOL implantation
October 15th 2006Charleston, SC-Pediatric cataract surgery with IOL implantation and primary posterior capsulectomy plus vitrectomy is associated with a satisfactory outcome, especially in children operated on after their first birthday, said Rupal H. Trivedi, MD, MSCR.
IOL combination provides optimal vision results
October 15th 2006Wilkes Barre, PA-Bilateral implantation of the apodized diffractive IOL (AcrySof ReSTOR, Alcon Laboratories) appears to result in a high rate of complaints about intermediate vision that can be completely mitigated by implanting the ReSTOR IOL in one eye and the second-generation refractive multifocal IOL (ReZoom, Advanced Medical Optics) contralaterally, according to a study by Frank A. Bucci Jr., MD, a private practitioner in Wilkes-Barre, PA.
Presoaked hydrophilic IOL alternative for prophylactic antibiotic delivery
October 15th 2006Salt Lake City-Implantation of a hydrophilic acrylic IOL (C-flex, Rayner) presoaked in a solution containing a fourth-generation fluoroquinolone resulted in anterior aqueous humor concentrations of antibiotic that were significantly higher and more persistent than what was achieved with a topical drop administration protocol, according to the results of a preclinical study undertaken by Guy Kleinmann, MD, and colleagues at the John A. Moran Eye Center, University of Utah Health Science Center, Salt Lake City.
OVD protects tissues, maintains space and clarity
October 15th 2006Previously, ophthalmic viscosurgical devices (OVDs) could be divided into two camps: dispersive OVDs and cohesive OVDs. Both have pros and cons. Cohesive OVDs create and maintain space, they don't trap air bubbles against the endothelium, and they are easy to remove at the end of the surgery. However, they don't coat tissues well.
Posterior polar cataracts necessitate special care
October 15th 2006Baltimore-Cataract surgery in eyes with posterior polar cataracts presents a special challenge, but safety may be optimized with a customized approach that recognizes that not all posterior polar cataracts are alike and employs techniques for minimizing the risk of posterior capsule rupture, said Robert S. Weinberg, MD.
Late optic calcification in hydrophilic acrylic lens poses vision risks
October 15th 2006Salt Lake City-Failure to recognize late opacification of the MemoryLens IOL (CIBA Vision) as a cause for vision problems can have potentially negative consequences, including unnecessary surgery and complications secondary to those procedures, said Jonathan G. Haymore, MD.
Residents' perspective on phaco
October 15th 2006Cataract surgery using phacoemulsification is perhaps the most important surgical procedure that ophthalmology residents learn during their 3 years of training and is the "bread-and-butter" procedure for practicing ophthalmologists. It goes without saying, therefore, that the entire ophthalmologic community should do its best to ensure outstanding training for the next generation-this usually requires both adequate surgical volume and excellent supervision by the attending surgeon.
Improving phaco skills of residents
October 15th 2006The subject of residents' surgical skills during phaco are coming under close scrutiny at various institutions. Two of three institutions concluded that the key to improved outcomes is adequate wet-lab training, expert supervision, and increased phaco conferences. The third is developing a valid instrument to evaluate performance during phaco; the results would provide immediate feedback to the resident by the attending surgeon.
Dr. de Juan endows $2.5M professorship at Wilmer
October 15th 2006Conduct an Internet search for references to Eugene de Juan, MD, and it will produce millions of results linking to his world-renowned son and retina specialist, Eugene de Juan Jr., MD. However, the junior Dr. de Juan wants the world to know and remember the great work of his general ophthalmologist father, who practiced with grace and compassion for more than 40 years in Mobile, AL.
Eye tissue issues could threaten ophthalmic research
October 15th 2006Rockville, MD-Vision and ophthalmic researchers in the United States have been narrowing their specifications for requested human eye tissue at the same time that the country's eye banks have been facing federal regulations and state laws that make it more difficult for them to meet these needs. The result is a reduction in tissue available for research. But researchers and eye banks can take steps to address this situation. Without such action, future research into some blinding diseases may be threatened.
Wilmer Eye Institute, Bascom Palmer take top honors in survey
October 15th 2006The results of Ophthalmology Times' 11th annual survey to determine the Best Overall programs as well as Best Clinical, Research, and Residency programs in ophthalmology lists many familiar names among the Top 10. The difference largely comes as they swap positions on the list, each jockeying for prominence in the hearts and minds of ophthalmology leaders nationwide.
Instrument cleaning, reprocessing implicated in reported TASS cases
October 15th 2006The ad hoc task force sponsored by the American Society of Cataract and Refractive Surgery (ASCRS) to investigate an increase in reported cases of toxic anterior segment syndrome (TASS) issued its final report on Sept. 25, 2006.